• Date

    Saturday, November 2, 2019
    09:00 am – 02:30 pm

  • Location

    Live Symposium
    UIC College of Pharmacy
    833 S. Wood Street
    Room 134-1
    Chicago, IL 60612

    Live Broadcast
    UIC College of Pharmacy (Rockford)
    1601 Parkview Ave,  Room E230
    Rockford, Illinois 61107

  • Fee

    Regular Rate: $40.00 (after Friday, August 30, 2019)

    Deadline Friday, October 25, 2019 
    Click here to register

Target Audience

Pharmacists and other health care professionals who care for patients with cancer.

Program Description

New developments in pharmacotherapy and a better understanding of cancer origins continue to revolutionize the treatment of patients with cancer and challenge the clinical pharmacist to stay abreast of emerging therapies with novel toxicities. This conference will examine approaches to the treatment of hematologic malignancies and provide an overview of new drug therapies. Highlighted topics will include a review of the improvements in the assessment and management of Graft versus Host Disease (GVHD), updates in Chronic Lymphocytic Leukemia ​(CLL), updates in Hepatocellular Carcinoma (HCC), and new drug updates in Oncology. In addition, the symposium will include a session on Assessment and Management of Cancer Pain in the Setting of the Opioid Epidemic.

Registration Information

Registration Fee: $40.00

Registration fee includes 3.75 contact hours of continuing pharmacy education credit, electronic handout, continental breakfast, lunch, and parking.

Space is limited and early registration is encouraged.


Registration Deadline: Friday, October 25, 2019

Please Note: All audience response questions, such as pre- and post-tests and active learning questions, will be conducted via the internet. Attendees must bring a smartphone, tablet, or laptop to this conference in order to participate in these activities and earn CE credits.


  • Amgen
  • Astellas
  • Astra Zeneca
  • Bayer
  • Celgene
  • Coherus BioSciences
  • Eisai
  • Genentech
  • Immunomedics
  • Incyte Corporation
  • Ipsen Biopharmaceuticals
  • Lilly Oncology
  • Merck
  • Novartis Hematology
  • Novartis Oncology
  • Pharmacyclics LLC
  • Pfizer
  • Puma Biotechnology
  • Sandoz
  • Sanofi Genzyme
  • Seattle Genetics

Interested in exhibiting? Click here for registration

Program Chair

Sandra Cuellar, PharmD, BCOP
Director, Specialty Residency in Oncology 
Clinical Assistant Professor, Department of Pharmacy Practice 
Clinical Pharmacist, Oncology 
University of Illinois at Chicago, College of Pharmacy
Chicago, Illinois